PREGEN (TRANSgenID)

Natural phenomena impact our lives, some positively and others negatively. Predictive genetic analysis, or "PREGEN (TRANSgenID)," can help manage these effects

PREGEN (TRANSgenID) – It is required Only “ONCE in Your Lifetime” 

Here are a few of the other reasons for “PREDICTIVE” becoming a necessity for all of us: 

Human lifespan is increasing, with 80+ years now being normal. Smaller families mean better planning is needed for the last 20-25 years of life in terms of health 

Those born between the 1950s and 1980s have experienced significant environmental and lifestyle changes. Scientific research in epigenetics has shown that external factors can impact our genes, leading to the development of new health conditions in both individuals under 45 and their children

Our understanding of medical conditions impacting past generations is improving, but many uncertainties remain about their genetic impact on future generations. 

Genetic anomalies: The COVID-19 pandemic resulted in seemingly healthy individuals facing severe outcomes. Ongoing studies suggest that existing genetic anomalies may have played a role in these cases

Medical advancements have expanded treatment options for many diseases, but there is also a rise in co-morbidities affecting patients and even leading to mortality. Understanding one's genetic makeup can be valuable for preventive and curative approaches. Advances in science and medicine are leading to more precise and personalized curative treatments, driven by improved genetic insights

The inputs and advancements in our understanding of genetic makeup allow us to plan for our future health. Prevention is better than an expensive cure. PREGEN(TRANSgenID) offers a predictive genetic analysis for the first time in India, which is not diagnostic

Key Features: 

1. Only 5 ml of peripheral blood is needed for a sample. 
2. Primary and progenitor stem cells are used for genetic analysis. 
3. Covers 20,000+ genes for comprehensive predictive genetic analysis. 
4. Predicts various diseases and conditions caused by genetic anomalies. 
5. Uses advanced sequencing and bioinformatics technologies. 
6. Includes nutrigenomics and pharmacogenomics analysis

PREGEN (TRANSgenID) assesses "Benign" indicators for their potential to trigger medical conditions related to lifestyle and diet. The report is generated within 45 days and provides essential details for further consultation, enabling preventive measures to minimize future expenses and pain

Due to a restructuring within the Transcell group, Pregen(TRANSgenID) has been added to Biolife's portfolio from Oncologics